Julio C. Chavez, M.D., M.S.

Julio C. Chavez, M.D., M.S., is a hematologist and oncologist in the Division of Hematology/Oncology at Mayo Clinic hospital in Jacksonville, Florida. He is currently the lead for the Lymphoma program and CAR-T research. Among other duties, he is the Vice-Chair for the Protocol Review Monitoring Core at Mayo Clinic.

Dr. Julio Chavez, received his medical degree from the Universidad Peruana Cayetano Heredia in Lima, Peru. He completed his Internal Medicine Residency at the University at Buffalo in 2011. He completed his fellowship in Medical Oncology at Moffitt Cancer Center/University of South Florida 2013. He is certified by the American Board of Internal Medicine with specialties in Internal Medicine and Medical Oncology.

Dr. Chavez has almost 15 years of experience as Clinical Investigator. He was Principal Investigator of several clinical trials for cellular immunotherapies, bispecific antibodies and targeted agents. Most notable, pivotal clinical trials such as ZUMA-1, ZUMA-5, ZUMA-7, ZUMA-12, ELARA and TRANSFORM. His work led to over 170 peer reviewed publications in high impact journals such as New England Journal of Medicine (1), Nature Medicine (4), Lancet Oncology (2), Journal of Clinical Oncology (6) and Blood (10).

At Mayo Clinic Jacksonville, Dr. Chavez is expected to apply his broad experience to further advance the treatment of lymphoma, lead the Lymphoma program and Cell Therapy Research.

In his free time, Dr. Chavez enjoys traveling, tennis, biking, swimming and reading history.